Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Nuntana Kasitanon"'
Autor:
Worawit Louthrenoo, Nuntana Kasitanon, Antika Wongthanee, Yuko Okudaira, Asuka Takeuchi, Hiroshi Noguchi, Hidetoshi Inoko, Fujio Takeuchi
Publikováno v:
Biomedicines, Vol 12, Iss 6, p 1347 (2024)
This study aimed to clarify the association of HLA Class I and II with dcSSc and lcSSc in Thais. HLA typing for 11 gene loci (Class I: HLA-A, B and C, and Class II [HLA-DR, DP and DQ]) was carried out using the Next Generation DNA Sequencing method (
Externí odkaz:
https://doaj.org/article/17498fb5155c4a3d9d57333a402d7e86
Publikováno v:
Advances in Rheumatology, Vol 63, Iss 1, Pp 1-10 (2023)
Abstract Background Several studies have compared the clinical features and outcomes of late- and early-onset systemic lupus erythematosus (SLE) patients. However, these previous studies were uncontrolled. The current study aimed to compare late- and
Externí odkaz:
https://doaj.org/article/f85453651172495f944c9f01391e3a56
Publikováno v:
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-12 (2020)
Abstract Background The utility of generic health-related quality of life (HRQoL) questionnaires in patients with systemic lupus erythematosus (SLE) is uncertain. We compared the performance of generic (SF36) and specific (SLEQOL) HRQoL surveys by ex
Externí odkaz:
https://doaj.org/article/655aeef1932b4bfc98a8597747b44fdc
Autor:
Thanika Ketpueak, Wanitcha Chanloung, Kittiya Na Nan, Chontara Pongsananurak, Nuntana Kasitanon, Worawit Louthrenoo
Publikováno v:
Clinical Rheumatology. 41:3887-3896
Scleroderma is a rare complication in taxanes therapy. Although individual cases of taxanes-induced scleroderma have been reported, the clinical manifestation and treatment outcomes were reviewed and summarized rarely. This study reported a patient w
Autor:
Nuntana Kasitanon, Laniyati Hamijoyo, Meng Tao Li, Kenji Oku, Sandra Navarra, Yoshiya Tanaka, Chi Chiu Mok
Publikováno v:
International Journal of Rheumatic Diseases. 25:1220-1229
The prevalence of systemic lupus erythematosus (SLE) is higher in Asians than Caucasians, with higher frequency of renal and other major organ manifestations that carry a poorer prognosis. The outcome of SLE is still unsatisfactory in many parts of t
Publikováno v:
Clinical Rheumatology. 41:2129-2141
To translate the Gout Assessment Questionnaire version 2.0 (GAQ2.0) with Gout Impact (GI) Scale (GIS) into Thai and determine its psychometric property in gout patients with acute arthritis (acute arthritis group) and during the intercritical period
Publikováno v:
Archives of Rheumatology. 37:361-374
Objectives: This study aims to compare pregnancy outcomes between systemic lupus erythematosus (SLE) patients who attained clinical remission based on the Definition of Remission in SLE (DORIS) and those with lupus low disease activity based on Low L
Autor:
Nuntana Kasitanon, Sang Cheol Bae, Meng Tao Li, Laniyati Hamijoyo, Sandra V. Navarra, Der Yuan Chen, Leonid Zamora, Eric F Morand, Sheng Chen, Yoshiya Tanaka, Kenji Oku, Kunihiro Yamaoka, Chi Chiu Mok
Publikováno v:
The Lancet Rheumatology. 3:e517-e531
Summary Systemic lupus erythematosus (SLE) is prevalent in Asia and carries a variable prognosis among patients across the Asia-Pacific region, which could relate to access to health care, tolerability of medications, and adherence to therapies. Beca
Autor:
Worawit Louthrenoo, Nuntana Kasitanon, Antika Wongthanee, Yuko Okudaira, Masumi Takeuchi, Fumiaki Nakajima, Miwa Habata, Anri Masuya, Hiroshi Noguchi, Hidetoshi Inoko, Fujio Takeuchi
Publikováno v:
HLAREFERENCES. 100(6)
HLA studies in patients with systemic sclerosis (SSc) have shown variable results. This study aimed to examine the association of HLA class I and II risk alleles in Thai SSc patients, and clarify the contribution of risk HLA alleles to the pathogenes
Publikováno v:
International Journal of Neuroscience. 132:868-873
Purpose of the study: Parkinsonism in patients with systemic lupus erythematosus (SLE) is rare. This study reported a case of parkinsonism in SLE and reviewed the clinical features and outcomes of ...